Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Net Margin (2017 - 2020)

Historic Net Margin for Cogent Biosciences (COGT) over the last 4 years, with Q3 2020 value amounting to 18325.64%.

  • Cogent Biosciences' Net Margin fell 171567200.0% to 18325.64% in Q3 2020 from the same period last year, while for Jun 2021 it was 21974.68%, marking a year-over-year decrease of 218778100.0%. This contributed to the annual value of 1042.5% for FY2020, which is 9010100.0% down from last year.
  • Latest data reveals that Cogent Biosciences reported Net Margin of 18325.64% as of Q3 2020, which was down 171567200.0% from 1401.52% recorded in Q2 2020.
  • In the past 5 years, Cogent Biosciences' Net Margin ranged from a high of 15.02% in Q4 2019 and a low of 18325.64% during Q3 2020
  • For the 4-year period, Cogent Biosciences' Net Margin averaged around 1632.07%, with its median value being 325.94% (2017).
  • Over the last 5 years, Cogent Biosciences' Net Margin had its largest YoY gain of 2962600bps in 2020, and its largest YoY loss of -171567200bps in 2020.
  • Over the past 4 years, Cogent Biosciences' Net Margin (Quarter) stood at 315.87% in 2017, then rose by 28bps to 226.18% in 2018, then surged by 107bps to 15.02% in 2019, then tumbled by -122069bps to 18325.64% in 2020.
  • Its Net Margin was 18325.64% in Q3 2020, compared to 1401.52% in Q2 2020 and 86.67% in Q1 2020.